PAVmed Inc. (PAVM) — Financial statements
Income statement, balance sheet, and cash flow for PAVmed Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.07↓97.6% | 3↑22.1% | 2↑550.4% | 0.38↓24.6% | 0.50 | |
| Cost of Revenue | 0.32↓94.7% | 6↓6.0% | 6↑77.6% | 4↑517.8% | 0.59 | |
| Gross Profit | -0.25↑91.7% | -3↑23.3% | -4↓22.6% | -3↓3708.2% | -0.09 | |
| Operating Expenses | ||||||
| R&D Expenses | 4,492↑75624.9% | 6↓58.4% | 14↓43.7% | 25↑27.7% | 20 | |
| General & Administrative Expenses | 16,250↑66161.6% | 25↓20.8% | 31↓25.3% | 41↑62.0% | 26 | |
| Selling & Marketing Expenses | 917↑7786.8% | 12↓33.9% | 18↓9.0% | 19↑117.2% | 9 | |
| SG&A Expenses | 17,167↑47386.9% | 36↓25.5% | 49↓20.1% | 61↑76.2% | 34 | |
| Other Expenses | -21,637↓3386041.8% | -0.64↓131.6% | 2↑13.3% | 2 | 0.00 | |
| Operating Expenses | 22↓48.0% | 41↓36.1% | 65↓26.2% | 88↑61.8% | 54 | |
| Total Costs & Expenses | 22↓53.9% | 47↓33.4% | 71↓22.1% | 91↑66.6% | 55 | |
| Operating Results | ||||||
| Operating Income | -22↑51.0% | -44↑35.3% | -69↑24.5% | -91↓67.5% | -54 | |
| Depreciation & Amortization | 0.11↓91.2% | 1↓59.1% | 3↑19.3% | 2↑987.2% | 0.23 | |
| EBITDA | -22↓173.1% | 30↑139.2% | -76↑23.9% | -100↓78.0% | -56 | |
| EBIT | -22↓176.6% | 28↑136.2% | -79↑22.8% | -102↓81.7% | -56 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.01↓96.2% | 0.21↑348.8% | -0.08↑92.4% | -1 | 0.00 | |
| Interest Income | 0.03↓88.6% | 0.25↓49.7% | 0.51↑198.8% | 0.17 | 0.00 | |
| Interest Expense | 0.02↓53.3% | 0.05↓92.4% | 0.59↓54.0% | 1 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -73↓838.5% | 10↓9.1% | 11↑527.2% | 2 | |
| Other Income / Expenses | 19↓73.5% | 73↑796.5% | -10↑13.9% | -12↓601.2% | -2 | |
| Income Before Tax | -2↓108.7% | 28↑135.9% | -79↑23.2% | -103↓83.9% | -56 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -2↓108.7% | 28↑135.9% | -79↑23.2% | -103↓83.9% | -56 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 0.40↓99.0% | 40↑162.0% | -64↑27.9% | -89↓76.7% | -50 | |
| Bottom-Line Net Income | -4↓111.7% | 32↑148.9% | -66↑25.8% | -89↓76.3% | -51 | |
| EPS (Basic) | -5.63↓105.7% | 99.15↑136.1% | -274.92↑39.0% | -450.95↓53.4% | -293.92 | |
| EPS (Diluted) | -5.63↓137.8% | 14.88↑105.4% | -274.92↑39.0% | -450.95↓53.4% | -293.92 | |
| Weighted Average Shares | 0.67↑108.0% | 0.32↑33.7% | 0.24↑21.8% | 0.20↑14.9% | 0.17 | |
| Weighted Average Diluted Shares | 0.67↓69.2% | 2↑802.9% | 0.24↑21.8% | 0.20↑14.9% | 0.17 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.